ISSN 2756-3340
African Journal of Infectious Diseases Research | Vol. 13, No. 7, July 2026 | pp. 508–515
DOI: 10.46882/AJIDR/148981
Article Type: Research Article
Title: Antiviral resistance mutations and viral load kinetics in chronic hepatitis C virus genotype 4 patients failing direct-acting antivirals
Names of Authors: Omar El-Sayed¹*, Claudia Weber², Rohan Deshmukh³
Abstract: Direct-acting antivirals achieve high sustained virologic response rates in chronic hepatitis C, yet baseline or treatment-emergent resistance-associated substitutions can cause virologic failure. We analyzed NS3, NS5A, and NS5B resistance polymorphisms in genotype 4 patients who experienced virologic breakthrough. Plasma samples from 112 treatment-experienced patients underwent population sequencing and quantitative viral load monitoring at baseline and relapse. NS5A substitutions at positions L28M and Y93H were present in 78.6 percent of non-responders, significantly impairing sofosbuvir-daclatasvir efficacy. Resistance-guided salvage regimens restore high cure rates in difficult-to-treat cohorts.
Keywords: Hepatitis C virus, Direct-acting antivirals, Resistance-associated substitutions, Genotype 4, Virologic failure
Citation: El-Sayed O, Weber C, Deshmukh R (2026). Antiviral resistance mutations and viral load kinetics in chronic hepatitis C virus genotype 4 patients failing direct-acting antivirals. African Journal of Infectious Diseases Research, 13(7): 508–515. DOI: 10.46882/AJIDR/148981
Manuscript Timeline: Received: June 01, 2026; Revised: June 30, 2026; Accepted: July 17, 2026; Published: July 24, 2026
Subscribe to read the full article: https://mail.internationalscholarsjournals.org/subscribe-to-read